⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20931143 | 1.00 | — | — | |
| SCHEMBL9871440 | 0.88 | MAPT (0.30) | — | |
| SCHEMBL11606981 | 0.86 | — | — | |
| SCHEMBL22920974 | 0.75 | — | — | |
| SCHEMBL23631117 | 0.72 | — | — | |
| SCHEMBL146924 | 0.72 | — | — | |
| SCHEMBL14749922 | 0.72 | — | — | |
| SCHEMBL6720332 | 0.72 | — | — | |
| SCHEMBL6715928 | 0.72 | — | — | |
| SCHEMBL2080415 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 233 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4973708-A | TRANSDERMAL ENHANCER FOR PENETRATION OF DRUGS THROUGH THE SKIN | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 1990-11-27 | — | — | US | claimed |
| US-20260108546-A1 | GIP RECEPTOR AGONIST COMPOUNDS | LILLY CO ELI (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260042765-A1 | PYRROLOTRIAZINE COMPOUNDS AS TAM INHIBITORS | INCYTE CORP (US) | 2026-02-12 | — | — | US | disclosed |
| EP-4676923-A1 | BIARYLAMIDE DERIVATIVES AND THEIR USE AS PKMYT1 INHIBITORS | Cancer Research Technology Limited (GB) | 2026-01-14 | — | — | EP | disclosed |
| WO-2025264700-A1 | GIP RECEPTOR AGONIST COMPOUNDS | ELI LILLY AND COMPANY (US) | 2025-12-26 | — | — | WO | disclosed |
| EP-4653438-A1 | MACROCYCLIC COMPOUNDS, PREPARATION METHOD THEREFOR, AND USE THEREOF | Genfleet Therapeutics (Shanghai) Inc. (CN) | 2025-11-26 | — | — | EP | disclosed |
| EP-4619397-A1 | SALT-INDUCIBLE KINASES (SIK) INHIBITORS AND METHODS OF USES THEREOF | Insilico Medicine IP Limited (HK) | 2025-09-24 | — | — | EP | disclosed |
| US-12415809-B2 | Pyrrolotriazine compounds as tam inhibitors | INCYTE CORPORATION (US) | 2025-09-16 | — | — | US | disclosed |
| EP-4585265-A2 | HETEROARYL INHIBITORS OF PLASMA KALLIKREIN | Takeda Pharmaceutical Company Limited (JP) | 2025-07-16 | — | — | EP | disclosed |
| EP-4251620-B1 | AMINO QUINAZOLINE DERIVATIVES AS P2X3 INHIBITORS | CHIESI FARM SPA (IT) | 2025-04-16 | — | — | EP | disclosed |
| EP-0101265-B1 | NOVEL CEPHALOSPORIN COMPOUNDS AND PREPARATION THEREOF | Tanabe Seiyaku Co., Ltd. (JP) | 1988-06-29 | — | — | EP | disclosed |
| US-4742174-A | MICROBTOCIDES | TANABE SEIYAKU CO., LTD. (JP) | 1988-05-03 | — | — | US | disclosed |
| US-4727071-A | MICROBIOCIDES | TANABE SEIYAKU CO., LTD. (JP) | 1988-02-23 | — | — | US | disclosed |
| EP-0245619-A1 | Novel thiazolylacetic acid derivatives and processes for preparing the same | Tanabe Seiyaku Co., Ltd. (JP) | 1987-11-19 | — | — | EP | disclosed |
| US-4598154-A | Thiazole intermediates for cephalosporin compounds | TANABE SEIYAKU CO., LTD. (JP) | 1986-07-01 | — | — | US | disclosed |
| US-4598075-A | ANTIMICROBIAL | TANABE SEIYAKU CO., LTD. (JP) | 1986-07-01 | — | — | US | disclosed |
| EP-0147181-A2 | Thiazolylacetic acid derivatives and their preparation | Tanabe Seiyaku Co., Ltd. (JP) | 1985-07-03 | — | — | EP | disclosed |
| EP-0101265-A2 | Novel cephalosporin compounds and preparation thereof | Tanabe Seiyaku Co., Ltd. (JP) | 1984-02-22 | — | — | EP | disclosed |
| US-4067985-A | IMMUNOSUPPRESSIVE, SEDATIVE, ANTITUMOR | CHEMIE GRUNENTHAL GMBH (DT) | 1978-01-10 | — | — | US | disclosed |
| US-3951985-A | SUBSTITUTED ORTHO-SULFOBENZOIC ACID IMIDO PYRROLIDONE, PIPERIDONE OR CAPROLACTAM | CHEMIE GRUNENTHAL GMBH (DT) | 1976-04-20 | — | — | US | disclosed |